Grifols SA (GRFS)
8.23
+0.32
(+4.05%)
USD |
NASDAQ |
Apr 30, 13:05
Grifols EPS Diluted (Quarterly) : 0.168 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Cellectis SA | -0.2621 |
| Trinity Biotech Plc | -0.274 |
| Akari Therapeutics Plc | 0.00 |
| NuCana Plc | -0.7979 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 146.39M |
| Revenue (Quarterly) | 2.307B |
| Total Expenses (Quarterly) | 2.192B |
| Enterprise Value | 17.42B |
| Gross Profit Margin (Quarterly) | 34.66% |
| Profit Margin (Quarterly) | 6.35% |
| Earnings Yield | 8.19% |
| Operating Earnings Yield | 25.29% |
| Normalized Earnings Yield | 7.820 |